• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • New Standalone Rules for the Classification of IVDs

New Standalone Rules for the Classification of IVDs

Monday, 22 November 2021 / Published in Medical Device, News, NMPA Registration in China

New Standalone Rules for the Classification of IVDs

On October 29, 2021, the NMPA (National Medical Products Administration) published the In Vitro Diagnostic Reagents Classification Rules for the first time as an individual document.  Previously, the classification rules for IVDs were only published in the 2014 version of the Administrative Measures for the Registration and Filing of IVDs.

Highlights

Criteria (* for clarified new items) to determine the product classification of:

Class I IVD reagents

  • Microorganism culture medium (not applicable to microorganism identification and drug sensitivity testing)
  • *Intended purpose of Class I IVDs can only be for the proliferation of cell culture (not applicable to cell selection, induction, and differentiation functions)
  • Cultured cells can only be intended for the in vitro diagnostics of cell culture medium.
  • Products for specimen treatment such as hemolytic agents, diluents, staining solutions, nucleic acid extraction reagent, etc.
  • *General reagents for the reaction system such as buffer, substrate solution, enhancement solution, etc.

Class II IVD reagents

  • Intended for protein testing.
  • *Intended for sugar testing.
  • Intended for hormone testing.
  • Intended for enzymes testing.
  • Intended for esters testing.
  • Intended for vitamin testing.
  • Intended for inorganic ion testing.
  • Intended for the testing of drugs and drug metabolites.
  • Intended for auto-antibody testing.
  • Intended for microorganism identification and medicine sensitivity experiment.
  • *Intended for the proliferation of cell culture (applicable to cell selection, induction, and differentiation functions).
  • *Intended for allergen testing (previously classified as Class III).
  • Intended for indices inspection such as physiological indices, biochemical indices and immune functions indices.

Class III IVD reagents

  • Reagents related to the testing of antigen, antibody and nucleic acid, etc. for pathogen.
  • Reagents related to blood type and tissue matching.
  • Reagents related to human genetic testing.
  • Reagents related to inherited diseases.
  • Reagents related to the testing of narcotic drugs, psychotropic drugs and toxic drugs for medical use.
  • Reagents related to the testing of targets of curative drugs.
  • *Reagents related to the testing for tumor screening, diagnosis, auxiliary diagnosis, staging, etc.

By Alice Liu and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: classification, IVD reagents, IVDs, medical device

What you can read next

China Regulatory Round-up for Medical Devices in March 2021
China General Cosmetics Urgent Deadline! Annual Reports Due 31 March
Clinical Trials GMP management
Use of Overseas Clinical Trial Data for IVDs

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.